Oncology
Photodynamic therapy for treating non-melanoma skin tumours
30 September 2021
Published on 30 Sep 2021
Last Updated on 30 Sep 2021
Guidance Recommendation
The Ministry of Health’s MTAC has not recommended subsidising photodynamic therapy in the treatment of non-melanoma skin tumours including actinic keratosis, basal cell carcinoma, and squamous cell carcinoma in situ (or Bowen’s disease).
Subsidy status
Photodynamic therapy is not recommended for subsidy in patients with the abovementioned indications.
Photodynamic therapy for treating non-melanoma skin tumours [PDF, 236 KB]